Cargando…
Diagnostic Value of Wilms Tumor 1 and CD44 in Langerhans Cell Sarcoma: Case Series of 4 Patients
Langerhans cell sarcoma (LCS) is a rare tumor with markedly malignant cytological features originating from Langerhans cells. LCS diagnosis is difficult and requires differentiation from other malignant tumors and Langerhans cell histiocytosis (LCH). Immunochemical antibodies, such as langerin, S-10...
Autores principales: | Wang, Chang-song, Chen, Yan-ping, He, Wei-hua, Yin, Jian, Gao, Chun-fang, Wang, Ping, Li, Hong, Lv, Xue-xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554032/ https://www.ncbi.nlm.nih.gov/pubmed/25837753 http://dx.doi.org/10.1097/MD.0000000000000636 |
Ejemplares similares
-
Prognostic value of CD44v9 expression in human cancers: A systematic review and meta-analysis
por: Zeng, Li, et al.
Publicado: (2020) -
Endometrial stromal sarcoma in combination with mixed type endometrial carcinomas: A case report and literature review
por: Xiu, Xiao-Xin, et al.
Publicado: (2017) -
Langerhans Cell Histiocytosis of the Clavicle: A Case Report and Review of the Literature
por: Wang, Shaowu, et al.
Publicado: (2014) -
Comprehensive analysis of immune implication and prognostic value of DHX33 in sarcoma
por: Zhang, Xinan, et al.
Publicado: (2023) -
Effects of flavopiridol on critical regulation pathways of CD133(high)/CD44(high) lung cancer stem cells
por: Bozok Cetintas, Vildan, et al.
Publicado: (2016)